- Hemato-Linné is an excellence research environment in hematopoiesis at Lund University.
- Financed by the Swedish Research Council through a 10-year Linnaeus grant, Hemato-Linné was established in 2006 as a world-leading research environment to study the regulation of normal and leukemic hematopoietic stem cells and blood lineage development.
- Hemato-Linné also focuses on excellence in research training and career development of young scientists.
Diamond Blackfan anemia (DBA) is a hypoplastic anemia (shortage of red cell production) that presents in early childhood as a moderate to severe anemia and many of the patients (40%) are transfusion-dependent for a lifetime. Practically all DBA patients have a mutation in one of the ribosomal protein genes. See our newly produced film about the disease.
On March 26th, Harvey F. Lodish gave a seminar on “Starting and developing biotechnology companies” Professor Lodish is from the Whitehead Institute for Biomedical Research, Professor of Biology and Professor of Bioengineering, Massachusetts Institute of Technology
Out of 51 applications three was granted the Young Investigator Award by the Swedish Cancer Society. Two of these, Göran Karlsson and Marcus Järås are both young Principal Investigators at the Department of Laboratory Medicine, Lund University, and are associated with the Hemato-Linné research environment. Göran Karlsson will study “Single cell molecular profiling for specification and therapeutic targeting of leukemic stem cells” and Marcus Järås project is about “Targeting leukemia stem cells using novel antibody therapies”